CSE: UDOC | FRA: L7T | OTCQB: UDOCF
Investor
Presentation
Click To
Download
News
Alerts
Click To
Sign Up

COMPANY

Market Demand

North America’s healthcare system is broken. We’re set to disrupt it. Let’s do it together.

With demand for modernized telehealth and virtual care solutions continually reaching new all-time highs, we believe the market is primed for incredible growth.

The Telehealth Market is estimated to grow from USD $24.6B in 2020 to USD $70.19B in 2026.
Source Link
In the US alone Telehealth Market is valued at USD 8.30 billion in 2019 and expected to reach USD $22.92 billion by 2025.
Source Link
0 +
Pharmacies in US
Source Link
0 +

Pharmacies in Canada

Source Link

Market Opportunity

Our Virtual Health Clinics are being developed and designed to target placement in pharmacies and publicly accessed spaces.

Easy access and contactless visits offer improved patient reach and growth opportunities in both rural and urban areas. In future, UniDoc intends to deploy its solution in locations such as: 

  • Grocery Stores
  • Long-Term Care Facilities
  • Pharmacies
  • Post-Secondary Education Campuses
  • Corporate Offices
  • And more…

5000+

HOSPITALS

4800

LABORATORIES

Our Advantage

Our first-to-execute position means delivering our solution to users faster.

We’re building trusted partnerships with renowned medical companies like Dedalus.

Dedalus is a billion-dollar healthcare company with extensive experience in connected care including hospital IT. Dedalus possess pharmacies across North America and support over 5000 hospitals and 4800 laboratories worldwide.

Better access to
healthcare is the future.

VIEW INVESTOR INFORMATION

Experienced Leadership

Our cross-functional team has a broad range of skills. We’re bringing this talent together across disciplines to change medicine for the better. Forever.

Management

Franco Staino

Chairman of the Board of Directors

Antonio Baldassarre

CEO, President and Director

Dr. Sazzad Hossain, PhD

Chief Scientific Officer

Sina Pirooz

Director

Matt Chatterton

Director

Austin Thornberry

Director

Roberto Caon

Advisor

CSE: UDOC | FRA: L7T | OTCQB: UDOCF
Investor Presentation

Subscribe to News Alerts

By submitting the form, you agree to receive communications from UniDoc Health.

"*" indicates required fields

Consent*

UniDoc Health Corp. © 2023. All rights reserved.

Facebook Twitter Instagram

Franco Staino

Chairman of the Board of Directors

Mr. Franco Staino is the Developer of the Italian National anti-counterfeiting Program for Pharmaceuticals developed in conjunction with the Ministry of Health as well as the National Certification Program for all unsold Prescription Drugs in Partnership with Pharmindustria (National association of all Pharmaceutical Manufactures) through ASSINDE.

Through one of his Companies, Carlucci are responsible for the control, labelling and collection of all pharmaceutical prescription drugs in Italy, under the PHG umbrella Franco opened first a UK division, now has also expanded into 4 African countries. Over the Years Franco has been a Board Member and Contributor on various International Committees, including the United Nations.

Antonio Baldassarre

CEO, President and Director

Mr. Baldassarre has held senior management and director positions of new business start-ups and established multinational organizations with over 30 years of experience in the Security, Information Technology and Communications industries. With leadership skills in management of international operations, shareholder exit strategies, and overall business development, he has utilized a wide range of strategic programs to maximize organic growth into specific industry segments through OEM, alliances, and direct multi-level distribution channels. Mr. Baldassarre is able to plan, organize and direct all aspects of a Corporation from Operations, P&L oversight, product distribution, Product promotions, sales and development activities and initiatives utilizing my extensive marketing/sales senior management experience with developed abilities in team leadership and program/campaign development. Directly involved in the growth, branding and ultimately optimizing market share, product awareness, revenues, profitability and shareholder value. Mr. Baldassare is also the President of LRG Security Canada Inc. and LRG Security Europe.

Dr. Sazzad Hossain, PhD

Chief Scientific Officer

He is the former Chief Scientific Officer of InMed Pharmaceuticals Inc., a leading public Canadian bio-pharmaceutical company. Previously he worked as Senior Scientist at Biotechnology Research Institute of National Research Council Canada. Working with the Canadian government he helped establish the pharmacology laboratory to evaluate safety and efficacy of cannabinoid-based and other drugs under development for cancer, cardiovascular and ocular diseases.

Sina Pirooz

Director

Mr. Pirooz is a registered and practicing pharmacist, and has been a professional member of the College of Pharmacists of British Columbia since 2003, with over 20 years of pharmaceuticals and pharmacy management experience. As owner of a compounding pharmacy, Mr. Pirooz has been dispensing pharmaceuticals for over 18 years and provides pharmacist and pharmacy management services to many of Canada’s largest pharmacy chains and drug stores. Mr. Pirooz is also the CEO and a director of Genix Pharmaceuticals Corporation, a company listed for trading on the TSXV.

Matt Chatterton

DIRECTOR

Mr. Chatterton brings over 15 years of experience in development and execution of complex projects. His expertise includes project management, facility management, logistics, supply side processes and procedures at several operations in Canada and internationally. He has been involved in the public markets for the last three years managing initial public offering processes and transitioning businesses to postlisting operations. Mr. Chatterton is a professional engineer and graduate of Canada’s Queens University with a master’s degree in chemical process engineering (2003).

Austin Thornberry

Director

Mr. Thornberry is a seasoned finance professional with a background in advising start-up companies in the venture capital market. He brings extensive experience working with high-growth companies across numerous industries through his past work in the technology and innovation banking group at the Bank of Montreal and in the financial services arm of Ernst & Young advising on multiple capital markets transactions. He obtained his bachelor of commerce at McGill University and has held the CPA, CA, designation since 2019.

Roberto Caon

Advisor

Mr. Caon is an elected member of the Italian Parliament. Since 2013, he has been a Member of the Italian Republic with the functions of: member of the Transport, Digitization, and Communications Commission of the Italian Parliament, member of the Bicameral Commission for Regional Affairs, and member of the Agriculture Commission. In Parliament, counted among his numerous successes, he has assisted with the implementation of various telemedicine services in the family sector. He has done this through the identification of innovative processes for patient care and the strengthening of multi-professional and multidisciplinary collaboration between different professionals. This work is now included in the proposed National Recovery and Resilience Plan, the 750 billion European plan that the member countries will use for the recovery of national economies, severely tested by the effects of the Covid-19 pandemic.

 

Prior to his current role in the Italian Parliament, Mr. Caon has spent over 30 years as an entrepreneur coordinating and designing solutions and technologies in the engineering, automotive and manufacturing sectors that are currently employed in 34 countries and used by hundreds of companies in both B2B and B2B2C environments. He held the role of owner and administrator of Giorgia Srl., a small / medium company active in the automotive and manufacturing engineering sector. He has worked extensively in the development of foreign markets for various companies in the metalworking and manufacturing sectors. He is currently a member of many trade associations linked to his extensive personal entrepreneurial background.

Sign Up For News Alerts

Enter your details below and we will add you to our News Alerts list.

Consent(Required)

Jacob Moshinsky

Chief Operating Officer

Jacob is the CEO & founder of MoviWear a GPS, fall down detection & remote vital-sign monitoring platform, alerting caregivers of real-time emergencies. Jacob is a communications and technology expert with over 15 years’ experience in the field. the NurtureWatch health monitoring Smartwatch and MoviWearMED remote vital sign monitoring platform Prior to MoviWear, Jacob worked in both the Canadian telecom and the CPG industry. He led the Product Development and Business Strategy team at TELUS for the Small Business Portfolio. Jacob also worked in various product and service management roles within Rogers Communications where he launched and managed wireless and wireline products.